| Primary |
| Product Used For Unknown Indication |
23.8% |
| Nausea |
9.9% |
| Prophylaxis Of Nausea And Vomiting |
8.5% |
| Vomiting |
8.1% |
| Drug Use For Unknown Indication |
5.8% |
| Maternal Exposure During Pregnancy |
5.4% |
| Hyperemesis Gravidarum |
4.8% |
| General Anaesthesia |
4.5% |
| Induction Of Anaesthesia |
3.8% |
| Pain |
3.6% |
| Antiemetic Supportive Care |
3.0% |
| Chemotherapy |
2.9% |
| Anaesthesia |
2.4% |
| Procedural Nausea |
2.4% |
| Prophylaxis |
2.4% |
| Tuberculosis |
2.1% |
| Depression |
1.9% |
| Analgesic Therapy |
1.9% |
| Maintenance Of Anaesthesia |
1.7% |
| Breast Cancer |
1.3% |
|
| Vomiting |
15.9% |
| Ventricular Tachycardia |
9.5% |
| Tremor |
7.5% |
| Death |
5.6% |
| Torsade De Pointes |
5.6% |
| Serotonin Syndrome |
5.0% |
| Unresponsive To Stimuli |
5.0% |
| Cardiomyopathy |
4.2% |
| Drug Ineffective |
4.2% |
| Loss Of Consciousness |
3.9% |
| Maternal Exposure During Pregnancy |
3.9% |
| Migraine |
3.9% |
| Maternal Drugs Affecting Foetus |
3.6% |
| Nausea |
3.6% |
| Tachycardia |
3.6% |
| Atrioventricular Block Complete |
3.1% |
| Febrile Neutropenia |
3.1% |
| Respiratory Arrest |
3.1% |
| Urticaria |
3.1% |
| Cardiac Arrest |
2.8% |
|
| Secondary |
| Prophylaxis Of Nausea And Vomiting |
27.8% |
| Product Used For Unknown Indication |
22.2% |
| Chemotherapy |
5.5% |
| Pain |
5.0% |
| Drug Use For Unknown Indication |
4.6% |
| Prophylaxis |
3.9% |
| Analgesic Therapy |
3.4% |
| Nausea |
3.3% |
| Anaesthesia |
2.8% |
| Mucosal Inflammation |
2.7% |
| Drug Abuse |
2.7% |
| Premedication |
2.4% |
| Bone Sarcoma |
2.2% |
| Vomiting |
2.2% |
| Constipation |
2.0% |
| Infection |
1.7% |
| Antiemetic Supportive Care |
1.6% |
| Depression |
1.3% |
| Neoplasm Malignant |
1.3% |
| Breast Cancer |
1.2% |
|
| Venoocclusive Liver Disease |
14.3% |
| Vomiting |
14.3% |
| Vena Cava Thrombosis |
11.7% |
| Febrile Neutropenia |
6.9% |
| Serotonin Syndrome |
5.4% |
| Completed Suicide |
4.5% |
| Ventricular Tachycardia |
4.1% |
| Death |
3.9% |
| Off Label Use |
3.7% |
| Maternal Exposure During Pregnancy |
3.3% |
| Torsade De Pointes |
3.3% |
| Thrombocytopenia |
3.2% |
| Malaise |
3.0% |
| Respiratory Arrest |
3.0% |
| Toxicity To Various Agents |
3.0% |
| Pain In Extremity |
2.8% |
| Pyrexia |
2.6% |
| Venoocclusive Disease |
2.6% |
| Arrhythmia |
2.2% |
| Drug Interaction |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
27.6% |
| Drug Use For Unknown Indication |
16.0% |
| Nausea |
8.1% |
| Prophylaxis |
7.3% |
| Pain |
6.1% |
| Premedication |
3.8% |
| Vomiting |
3.7% |
| Non-small Cell Lung Cancer |
3.5% |
| Hypertension |
3.2% |
| Breast Cancer |
3.2% |
| Prophylaxis Of Nausea And Vomiting |
2.8% |
| Constipation |
2.5% |
| Multiple Myeloma |
1.8% |
| Acute Myeloid Leukaemia |
1.7% |
| Chemotherapy |
1.7% |
| Colorectal Cancer Metastatic |
1.6% |
| Acute Lymphocytic Leukaemia |
1.4% |
| Colorectal Cancer |
1.4% |
| Anxiety |
1.3% |
| Depression |
1.3% |
|
| Vomiting |
22.8% |
| Thrombocytopenia |
7.5% |
| Weight Decreased |
6.3% |
| Pulmonary Embolism |
5.9% |
| Death |
5.3% |
| Nausea |
5.2% |
| White Blood Cell Count Decreased |
5.1% |
| Pyrexia |
5.0% |
| Pneumonia |
4.7% |
| Febrile Neutropenia |
4.4% |
| Sepsis |
3.6% |
| Renal Failure |
3.5% |
| Renal Failure Acute |
3.3% |
| Pain |
2.7% |
| Neutropenia |
2.7% |
| Tachycardia |
2.5% |
| Urinary Tract Infection |
2.5% |
| Dehydration |
2.4% |
| Diarrhoea |
2.3% |
| Septic Shock |
2.3% |
|
| Interacting |
| Product Used For Unknown Indication |
22.1% |
| Drug Use For Unknown Indication |
12.1% |
| Depression |
9.3% |
| Hepatosplenic Candidiasis |
8.6% |
| Anxiety |
4.3% |
| Histrionic Personality Disorder |
4.3% |
| Induction Of Anaesthesia |
4.3% |
| Anaesthesia |
3.6% |
| Insomnia |
3.6% |
| Postoperative Analgesia |
3.6% |
| Prophylaxis Of Nausea And Vomiting |
3.6% |
| Convulsion |
2.9% |
| Induction And Maintenance Of Anaesthesia |
2.9% |
| Nausea |
2.9% |
| Neuromuscular Blockade Reversal |
2.9% |
| Maintenance Of Anaesthesia |
2.1% |
| Thyroglossal Cyst Excision |
2.1% |
| Vomiting |
2.1% |
| Acute Leukaemia In Remission |
1.4% |
| Analgesic Therapy |
1.4% |
|
| Drug Interaction |
20.7% |
| Vomiting |
17.2% |
| Serotonin Syndrome |
6.9% |
| Sinoatrial Block |
6.9% |
| Sinus Bradycardia |
6.9% |
| Ventricular Tachycardia |
6.9% |
| Arrhythmia |
3.4% |
| Atrioventricular Block Second Degree |
3.4% |
| Bradycardia |
3.4% |
| Drug Toxicity |
3.4% |
| Electrocardiogram Qt Prolonged |
3.4% |
| Hyperreflexia |
3.4% |
| Myocardial Infarction |
3.4% |
| Neuroleptic Malignant Syndrome |
3.4% |
| Performance Status Decreased |
3.4% |
| Sinus Tachycardia |
3.4% |
|
